HeadaTerm
Fewer migraine days. No pills.
HeadaTerm 2 attaches magnetically to a gel electrode on the forehead and stimulates the supraorbital and supratrochlear nerves with 60 Hz, 250 µs pulses. The user sets one of nine intensity levels with a single button, and each session stops automatically after 60 minutes. It is FDA-cleared for over-the-counter use, charges by USB-C and comes with a head strap to keep the electrode in place.
Key specifications
Why the HeadaTerm 2
Prevention, over the counter
HeadaTerm 2 is FDA-cleared for over-the-counter prophylactic treatment of episodic migraine in adults, without a prescription.
Targets the forehead nerves
Low-frequency pulses act on the supraorbital and supratrochlear nerves under the forehead skin, the external trigeminal nerve stimulation approach.
Simple, one button
Press and hold to start, click to go up a level, double-click to go down; the device vibrates to confirm and switches off after 60 minutes.
Rechargeable and magnetic
The small main unit snaps onto the gel electrode by magnets and recharges by USB-C, replacing the disposable HeadaTerm 1.
Where it is used
Home use by adults with episodic migraine, recommended through neurology and headache clinics and supplied through pharmacies.
In the box
1 × HeadaTerm 2 device with electrodes (packs with 3, 6 or 9 electrodes on the official store); store images also show a carry case, head strap and USB-C charging cable. Pack sizes and configurations are confirmed with the quotation.
Clearance & compliance
FDA 510(k) cleared K230782 (26 Feb 2024), Class II, 21 CFR 882.5891, product code PCC, over-the-counter · CE 0537 marked per the HeadaTerm 2 instruction manual (EU authorised representative Riomavix S.L., ES-AR-000001202) · Health Canada Class II medical device licence 'TENS Device-HeadaTerm 2' (first issued 25 Sep 2024; licence image on watmedical.com). Supplied subject to registration in each destination country (MOHAP, DoH, DHA, SFDA or the equivalent authority). Certificates, declarations of conformity, IFUs and registration documents are provided with every quotation. Specifications are indicative and subject to manufacturer change.
Where a country has an official agent or authorised distributor, we source the item through it — or directly from the manufacturer if necessary. Product names, trademarks and images belong to their respective owners.
Questions
Is the HeadaTerm 2 available in the UAE and the GCC?
KGG sources the HeadaTerm 2 and its electrodes on request for pharmacies, clinics and distributors in the UAE, Saudi Arabia, Qatar, Kuwait, Bahrain and Oman. It is supplied subject to registration in each destination country, and availability is confirmed with each quotation.
How do I get a price?
Add it to your quote list or use Request a quote. We reply with pricing, lead time and the documents for your country, and can include electrode refill packs.
Does it treat a migraine attack?
No. HeadaTerm 2 is FDA-cleared for prevention of episodic migraine in adults. Devices cleared for acute treatment of an attack are a separate category.
How is it different from HeadaTerm 1?
HeadaTerm 1 is a prescription, disposable unit with a fixed number of sessions. HeadaTerm 2 is rechargeable, over the counter, has nine manual intensity levels and uses replaceable electrodes.
Who should not use it?
The manual lists brain implants, implanted or wearable defibrillators, epilepsy, arrhythmia, recent head or facial injury, brain tumour or stroke, and pregnancy among contraindications and precautions.
Can it be stored in Gulf heat?
Storage is rated from −20 to +55 °C and use from 5 to 40 °C. Keep it out of parked cars and direct sun in summer.
Request a quote
Get pricing for the HeadaTerm 2.
Tell us the quantity, delivery city and whether you are ordering for a facility, a team or a patient. We reply with pricing, lead time and the regulatory documents for your country.
English 
العربية